MENU
LCTX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Lineage Cell Therapeutics (LCTX) Ownership - Who owns Lineage Cell Therapeutics?
Profile
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
75
Web
https://www.lineagecell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
120.9M
P/E Ratio
N/A
Total Cash
32.71M
Projected Growth
N/A
Total Debt
2.75M
Revenue
8.72M
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash/Share
0.15
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
LCTX
Capitalization
121M
P/E Ratio
N/A
Risk (Beta)
1.45
Dividend Yield
N/A
Total Cash
32.7M
Total Cash/Share
0.15
Total Debt
2.75M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
8.72M
ROE
N/A
Book Value
66.2M
P/B Ratio
1.83
Cash Flow
N/A
Earnings
-0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
469M
Current Ratio
2.48
Current Revenue Per Employee
50386.67
Dividends Per Share - Security
N/A
EBITDA
-22.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.99
Revenue To Assets
-19.84
Shares Held By Institutions
106M
Shares Outstanding - Current
220M
Total Liabilities
31.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-49.679
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
75
Web
https://www.lineagecell.com